Qihan Biotech

Hangzhou, China · Founded 2017 · $90.8M raised

Headquarters
Hangzhou
Founded
2017
Business Model
B2B
Total Funding
$90.8M
Last Round
$16.0M Venture RoundSep 2023
Rounds
3

About

Qihan Biotech applies multiplexable genome editing and immune-shielding methods in human stem cells and animal germline cells to create immune-privileged allogeneic cells and xenogeneic organs. Its programs target cancer, organ failure, and other medical conditions, spanning organs such as kidney, heart, liver, and lung as well as cell types including islet cells, cardiomyocytes, neurons, and immune cells. Co-founded in 2017 by pioneers in genome editing, the company aims to make cell and organ therapies universally available to patients.

Summary

Qihan Biotech is a Biotech company based in Hangzhou, China, founded in 2017. It has raised $90.8M in total across 3 rounds, most recently a $16.0M Venture Round round in Sep 2023. Investors include Zhejiang Industrial Fund Co., Ltd., Lilly Asia Ventures and Sequoia Capital.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Venture RoundVenture RoundSep 2023
$16.0M

Sign up to see all 3 rounds

Series A through Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Qihan Biotech on Indexed.vc
<a href="https://indexed.vc/companies/qihan-biotech"><img src="https://indexed.vc/api/badge/company/qihan-biotech" alt="Qihan Biotech on Indexed.vc" width="260" height="76" /></a>